metricas
covid
Buscar en
Clínica e Investigación en Arteriosclerosis
Toda la web
Inicio Clínica e Investigación en Arteriosclerosis Levels of sCD163 in women rheumatoid arthritis: Relationship with cardiovascular...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Levels of sCD163 in women rheumatoid arthritis: Relationship with cardiovascular risk markers
Niveles de sCD163 en mujeres con artritis reumatoide: relación con los marcadores de riesgo cardiovascular
Oscar Zaragoza-Garcíaa, Olivia Briceñob, José Rafael Villafan-Bernalc, Ilse Adriana Gutiérrez-Péreza, Héctor Ugo Rojas-Delgadod, Gustavo Adolfo Alonso-Silverioa, Antonio Alarcón-Paredesa, José Eduardo Navarro-Zarzae, Cristina Morales-Martínezd, Rubén Rodríguez-Garcíaf, Iris Paola Guzmán-Guzmána,
Corresponding author
pao_nkiller@yahoo.com.mx

Corresponding author.
a Laboratory of Multidisciplinary Research and Biomedical Innovation, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, Mexico
b Infectious Diseases Research Center, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico
c Laboratory of Immunogenomics and Metabolic Diseases, Instituto Nacional de Medicina Genomica, Mexico City, Mexico
d Hospital General Dr. José G. Parres, Cuernavaca, Morelos, Mexico
e Hospital General Dr. Raymundo Abarca Alarcón, Chilpancingo, Guerrero, Mexico
f Laboratorio de Clínico, Instituto Mexicano del Seguro Social, Hospital General Regional, Cuernavaca, Morelos, Mexico
Read
9
Times
was read the article
1
Total PDF
8
Total HTML
Share statistics
Article information
ISSN: 02149168
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 June 6 0 6
2024 May 2 1 3

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos